1. AB0303 Tocilizumab in rheumatoid arthritis – annual interim analysis of the german non-interventional study ichiban. (23rd January 2014) Authors: Specker, C.; Kaufmann, J.; Kellner, H.; Bohl-Bühler, M.; Schwenke, H.; Vollmer, M. A.; Kapelle, A.; Zinke, S.; Hofmann, M. W.; Hellmann, P.; Fliedner, G. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0520 Tocilizumab in rheumatoid arthritis – one year interim analysis of the non-interventional ichiban study. (23rd January 2014) Authors: Specker, C.; Kaufmann, J.; Vollmer, M.A.; Kellner, H.; Bohl-Bühler, M.; Aringer, M.; Alberding, A.; Schwenke, H.; Kühne, C.; Lüthke, K.; Tony, H.P.; Zinke, S.; Kapelle, A.; Klopsch, T.; Aries, P.M.; Remstedt, S.; Melzer, A.; Hellmann, P.; Türk, S.; Fliedner, G. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0161 Discontinuation of Biologic Dmards Increases the Risk of Sepsis and Mortality After Serious Infection. (9th June 2015) Authors: Richter, A.; Strangfeld, A.; Schneider, M.; Klopsch, T.; Kapelle, A.; Kaufmann, J.; Zink, A.; Listing, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗